Rafael M Prieto Almirall

Rafael M Prieto Almirall is a notable inventor based in Palma De Mallorca, Spain. He has made significant contributions to the field of medical innovations, particularly in dialysis solutions. With a total of 4 patents, his work focuses on improving the health outcomes of patients undergoing dialysis.

Latest Patents

One of his latest patents is the "Composition of dialysis liquid comprising crystallisation inhibitor substances." This invention relates to a composition that includes inositol phosphates and/or bisphosphonates. It aims to prevent the loss of biologically important substances in patients undergoing dialysis, thereby maintaining sufficient physiological levels to regulate various processes. These substances serve as inhibitors of pathological crystallization. Another significant patent is the "Fixed-dose association of phytate and zinc." This invention describes a fixed-dose combination of phytate and zinc in synergistic proportions for treating the crystallization of hydroxyapatite. The molar ratio of phytate to zinc exceeds 4:1, making it advantageous for manufacturing a drug aimed at preventing hydroxyapatite crystallization in humans.

Career Highlights

Rafael has worked with the Universitat De Les Illes Balears, where he has contributed to research and development in his field. His innovative approaches have garnered attention and recognition within the medical community.

Collaborations

Throughout his career, Rafael has collaborated with notable colleagues, including Antonia Costa Bauza and Joan Perello Bestard. These partnerships have further enhanced his research and development efforts.

Conclusion

Rafael M Prieto Almirall stands out as an influential inventor in the realm of dialysis solutions. His patents reflect a commitment to improving patient care and advancing medical technology. His contributions continue to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.